
Smaller biopharma companies must do due diligence with their CMC strategy for BLA filings.
Khanh Ngo Courtney, PhD, is senior director of Biologics, Avomeen.
Published: October 15th 2021 | Updated:
259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.